The ability of cyclin D1 to drive the cell cycle forward can be blocked by cyclin D1-dependent kinase (CDK) inhibitors, such as p27 and p21, and can explain why co-expression of cyclin D1 and p21 contributed to the role of cyclin D1 for tumor proliferation. This evidence concerns the gene CCND1 and neoplasm.